Skip to article
Astra

Neonatology and congenital cardiology

Patent Ductus Arteriosus

Manage PDA by separating preterm ductal patency from a clinically consequential shunt and from persistent congenital PDA in older patients. Echocardiography establishes anatomy and physiology; treatment is reserved for hemodynamic consequences, with transcatheter closure increasingly favored when definitive intervention is required.

Clinical question: How should physicians evaluate hemodynamic significance and select observation, pharmacotherapy, transcatheter closure, or surgery for PDA?

First decision

Separate transitional preterm PDA from a significant shunt or persistent congenital lesion

The management target is hemodynamic consequence, not ductal patency alone.

In a preterm infant, obtain echocardiography when clinical findings raise concern for a left-to-right ductal shunt with pulmonary overcirculation or systemic hypoperfusion, or when escalating respiratory support prompts a physiology-based assessment. Echocardiography confirms PDA and defines ductal size, shunt direction, and the cardiovascular consequences that determine whether observation or closure-directed therapy is appropriate. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenWileyEchocardiography for Patent Ductus Arteriosus Including Closure in ...WileyEffect of patent ductus arteriosus on pulmonary vascular disease

Do not equate a large ductal diameter with a hemodynamically significant PDA. Size-based thresholds correlate with echo-derived shunt-volume markers but are surrogate measures; the actionable assessment incorporates shunt direction and pattern, indices of pulmonary overcirculation, and markers of systemic hypoperfusion. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenWileyRelationship of Patent Ductus Arteriosus Echocardiographic ...

In term infants, children, and adults, a persistent PDA is a congenital left-to-right shunt lesion rather than a transitional finding. Evaluate for left-heart volume overload, arrhythmia, and pulmonary hypertension; advanced pulmonary vascular disease may progress to Eisenmenger syndrome and materially changes closure candidacy. Wolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in ReviewWileyEffect of patent ductus arteriosus on pulmonary vascular disease

Clinical branch points that determine PDA management. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenWolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in ReviewWileyRelationship of Patent Ductus Arteriosus Echocardiographic ...WileyEffect of patent ductus arteriosus on pulmonary vascular diseasejtcvsManagement of premature infants with patent ductus arteriosus ...
Clinical settingKey discriminatorNext action
Preterm infant with PDAEcho shows ductal shunt physiology without compelling pulmonary overcirculation or systemic hypoperfusionUse conservative observation with serial clinical and echocardiographic reassessment; spontaneous closure is common. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenjtcvsManagement of premature infants with patent ductus arteriosus ...
Preterm infant with suspected hsPDAIntegrated evidence of shunt direction/pattern, pulmonary overcirculation, and systemic hypoperfusionConsider selective pharmacologic closure or definitive closure according to clinical course, contraindications, and local procedural capability. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsPubMedAnesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI Bookshelf
Term infant or childPersistent PDA with anatomy suitable for device treatmentPlan transcatheter closure. BMJPatent ductus arteriosus - Symptoms, diagnosis and treatment | BMJ Best Practice USWolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in Review
Adult with PDAEvaluate left-heart volume load, arrhythmia, and pulmonary vascular disease before closureUse adult congenital heart disease assessment to determine closure strategy and exclude clinically consequential pulmonary vascular disease. jaccMANAGEMENT DECISIONS FOR THE ADULT PATIENT WITH A ...Wolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in Review

Diagnostic workup

Use echocardiography to establish anatomy, shunt direction, and organ-level consequences

A complete study should answer whether the ductus is causing a clinically relevant circulatory state.

For preterm PDA assessment, document ductal size, shunt direction, and shunt pattern; then measure or qualitatively assess left-heart volume loading, pulmonary overcirculation, and systemic hypoperfusion. The IWOA score is one physiology-oriented approach that incorporates these features; higher scores indicate greater hemodynamic significance. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics Open

Interpret echocardiographic findings in the context of respiratory and perfusion trajectory. A persistent left-to-right shunt has been associated with bronchopulmonary dysplasia risk, but association does not establish that every detectable shunt requires closure. The LancetCardiac catheterisation for closure of patent ductus arteriosusjtcvsManagement of premature infants with patent ductus arteriosus ...

Ensure image acquisition and Doppler alignment are adequate before making an intervention decision. In a targeted neonatal echocardiography pathway, archived studies underwent offline review to confirm completeness of views, measurement accuracy, and appropriate Doppler alignment; this is particularly relevant when serial studies are used to justify escalation. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics Open

Before catheter or surgical intervention, use echocardiography to define ductal anatomy and procedural suitability. Echocardiography confirms the diagnosis and guides catheter-based and surgical intervention planning. WileyEchocardiography for Patent Ductus Arteriosus Including Closure in ...

Preterm infants

Select closure therapy only for persistent hemodynamic consequences

Observation and selective intervention should be individualized to physiology and clinical trajectory.

Most premature infants with PDA will experience spontaneous closure regardless of pulmonary disease. This natural history supports expectant management for infants without a clearly consequential shunt and avoids exposing all infants with PDA to medical or procedural adverse effects. jtcvsManagement of premature infants with patent ductus arteriosus ...

When an infant has persistent hemodynamic significance with cardiopulmonary compromise, choose among pharmacologic therapy, transcatheter closure, and surgical ligation after considering renal function, bleeding risk, sepsis, coagulopathy, anatomy, and access to experienced procedural teams. Conservative management, pharmacologic intervention, surgery, and transcatheter closure are all used for hemodynamically significant PDA. NaturePatent ductus arteriosus treatment trends and associated morbidities in neonates | Scientific ReportsScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsPubMedAnesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI Bookshelf

A targeted neonatal echocardiography screening pathway in infants born before 29 weeks' gestation was associated, in a pre-post observational study, with fewer invasive-ventilation days, lower BPD rates, and no surgical ligations in the post-screening period despite similar medical-treatment rates. Use this evidence to support physiology-guided selection, not to infer that screening itself causally improves outcomes. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics Open

Selective preterm PDA treatment options and practical constraints. BMJPatent ductus arteriosus - Symptoms, diagnosis and treatment | BMJ Best Practice USScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsPubMedAnesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI BookshelfScienceDirectOral pharmacological treatment for patent ductus arteriosus in premature neonates with hemodynamic repercussions
OptionWhen it fitsMajor limitation or next step
Observation with serial assessmentPDA is present but integrated echocardiography and clinical course do not show compelling hemodynamic consequencesContinue clinical and echocardiographic surveillance because spontaneous closure is common. BMJEarly protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics OpenjtcvsManagement of premature infants with patent ductus arteriosus ...
IndomethacinPreterm infant selected for pharmacologic closure without sepsis, renal insufficiency, or bleeding disorderA cited IV course is 0.1-0.2 mg/kg for three doses at 12- or 24-hour intervals; monitor renal, gastrointestinal, and platelet-related effects. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect Topics
Ibuprofen or acetaminophenAlternative pharmacologic approaches for selected preterm infantsReassess closure and hemodynamic status after treatment; evidence and selection practices vary. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsScienceDirectOral pharmacological treatment for patent ductus arteriosus in premature neonates with hemodynamic repercussions
Transcatheter closurePersistent significant PDA after medical therapy or contraindication to pharmacotherapy when anatomy and expertise permitMonitor for post-transcatheter cardiorespiratory instability. BMJPatent ductus arteriosus - Symptoms, diagnosis and treatment | BMJ Best Practice USNatureComparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation | Journal of PerinatologyPubMedAnesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI Bookshelf
Surgical ligationDefinitive closure required but catheter closure is not feasible or anatomy favors surgeryAnticipate postoperative cardiorespiratory instability and surgical complications. NatureComparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation | Journal of PerinatologyWolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in ReviewScienceDirectCatheter-based closure of the patent ductus arteriosus in lower weight infants - ScienceDirect

Pharmacologic closure

Cyclooxygenase inhibition with indomethacin or ibuprofen can induce PDA closure in premature infants; acetaminophen is another pharmacologic option. Indomethacin is generally ineffective in term infants and older patients, so do not extrapolate preterm drug-closure strategies to persistent congenital PDA outside prematurity. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect Topics

A cited intravenous indomethacin regimen is three doses of 0.1-0.2 mg/kg at 12- or 24-hour intervals. Monitor urine output and renal status, gastrointestinal perfusion concerns, blood pressure, platelet-related bleeding risk, and clinical evidence of sepsis during selection and treatment. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsScienceDirectOral pharmacological treatment for patent ductus arteriosus in premature neonates with hemodynamic repercussions

Avoid or defer indomethacin when sepsis, renal insufficiency, or a bleeding disorder is present. Indomethacin can decrease renal and gastrointestinal blood flow and interfere with platelet function; reduced diuresis was reported in premature neonates receiving indomethacin. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect TopicsScienceDirectOral pharmacological treatment for patent ductus arteriosus in premature neonates with hemodynamic repercussions

Procedural management

Choose transcatheter closure when feasible; reserve surgery for anatomy or concomitant repair needs

Definitive treatment requires anatomy-based planning and post-closure surveillance.

Transcatheter closure is the preferred approach for most persistent PDA cases when anatomy and patient characteristics allow device deployment. In adults, surgical repair is generally reserved for distinct ductal anatomy or concurrent intracardiac pathology requiring surgery. Wolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in Review

In infants, transcatheter closure has become more common relative to surgical ligation. A pediatric administrative-database comparison cited lower mortality and shorter length of stay with transcatheter closure than surgical ligation, but procedure selection remains vulnerable to anatomic and illness-severity confounding. PubMedAnesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI Bookshelf

For very preterm infants, anticipate acute hemodynamic change after either modality. Post-ligation cardiac syndrome and post-transcatheter cardiorespiratory syndrome may occur; assess cardiovascular and respiratory status promptly after closure rather than attributing deterioration solely to lung disease. NatureComparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation | Journal of PerinatologyScienceDirectCatheter-based closure of the patent ductus arteriosus in lower weight infants - ScienceDirect

Persistent congenital PDA

Approach PDA in term patients, children, and adults as a congenital shunt lesion

Drug closure is not the strategy for persistent PDA beyond prematurity.

For term infants and children with a small-to-moderate PDA, transcatheter device closure is the usual definitive pathway. For large ducts or symptomatic infants too small for device closure, surgical closure may be required. BMJPatent ductus arteriosus - Symptoms, diagnosis and treatment | BMJ Best Practice US

In adults, quantify the clinical impact of the persistent shunt before intervention, specifically left-heart volume overload, arrhythmias, and pulmonary hypertension. Untreated PDA can progress to Eisenmenger syndrome; pulmonary vascular disease therefore requires deliberate hemodynamic and congenital-cardiology evaluation before closure. Wolters KluwerManagement of Patent Ductus Arteriosus in the... : Cardiology in ReviewWileyEffect of patent ductus arteriosus on pulmonary vascular disease

Indomethacin is rarely effective in full-term infants and older patients. Persistent congenital PDA should therefore be referred for device or surgical closure assessment rather than repeated prostaglandin-inhibitor courses. ScienceDirectDuctus Arteriosus Obliteration - an overview | ScienceDirect Topics

References

  1. Early protocol-based echocardiographic assessment and management of patent ductus arteriosus in infants less than 29 weeks’ gestation | BMJ Paediatrics Openbmjpaedsopen.bmj.com · bmjpaedsopen.bmj.com
  2. Cardiac catheterisation for closure of patent ductus arteriosuswww.thelancet.com · www.thelancet.com
  3. Patent ductus arteriosus - Symptoms, diagnosis and treatment | BMJ Best Practice USbestpractice.bmj.com · bestpractice.bmj.com
  4. MANAGEMENT DECISIONS FOR THE ADULT PATIENT WITH A ...www.jacc.org · www.jacc.org
  5. Outpatient Management of Isolated Left-to-Right Shunt Lesions in ...www.jacc.org · www.jacc.org
  6. Comparison of neurodevelopmental outcomes of extremely preterm infants undergoing trans-catheter closure of the patent ductus arteriosus compared to surgical ligation | Journal of Perinatologywww.nature.com · www.nature.com
  7. Patent ductus arteriosus treatment trends and associated morbidities in neonates | Scientific Reportswww.nature.com · www.nature.com
  8. Management of Patent Ductus Arteriosus in the... : Cardiology in Reviewjournals.lww.com · journals.lww.com
  9. Comparing transcatheter and surgical closure of... : Annals of Medicine & Surgeryjournals.lww.com · journals.lww.com
  10. Relationship of Patent Ductus Arteriosus Echocardiographic ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  11. Predictive Echocardiographic Parameters for Persistent ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  12. Echocardiography for Patent Ductus Arteriosus Including Closure in ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  13. Effect of patent ductus arteriosus on pulmonary vascular diseaseonlinelibrary.wiley.com · onlinelibrary.wiley.com
  14. Ductus Arteriosus Obliteration - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  15. Management of patent ductus arteriosus: A comparison of operative V pharmacologic treatment - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  16. Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  17. Catheter-based closure of the patent ductus arteriosus in lower weight infants - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  18. Diagnosis and Management of Patent Ductus Arteriosus | NeoReviewspublications.aap.org · publications.aap.org
  19. AAP clinical report updates guidance on managing patent ductus ...publications.aap.org · publications.aap.org
  20. Patent Ductus Arteriosus in Preterm Infants - AAP Publicationspublications.aap.org · publications.aap.org
  21. Prematurity and Congenital Heart Disease: A Contemporary Reviewpublications.aap.org · publications.aap.org
  22. Management of premature infants with patent ductus arteriosus ...www.jtcvs.org · www.jtcvs.org
  23. Anesthesia for Patients With Patent Ductus Arteriosus - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  24. Oral pharmacological treatment for patent ductus arteriosus in premature neonates with hemodynamic repercussionswww.sciencedirect.com · www.sciencedirect.com